Introduction: Post-transplant lymphoproliferative disease (PTLD) is a collection of conditions associated with
The incidence of PTLD varies from 1% to 20%, depending on the type of transplanted organ, age of patient, pre-transplant EBV status, type and dose of immunosuppression used 2 .
In a large transplant registry, PTLD incidence in children was found to be twice to an adult cohort 7 . The pediatric population is more susceptible to PTLD due to multitude of factors [6] [7] [8] .
First, due to younger age, they are more likely to be sero-negative at the time of transplantation with a greater risk of acquiring primary EBV infection afterward 6 . Second, they have a higher T cell levels and require more powerful post-transplant immunosuppression to prevent rejection 6 . As a result, the T cell response needed to fight EBV infection becomes more Our objective is to share our retrospective investigation for PTLD in the pediatric population in the past 10 years, focusing on otolarygological manifestations and evaluating the relationship between SOT and pathohistology of PTLD for this potentially fatal disease.
Methods:
We 
Results:
A total of 21 pediatric patients were included in this retrospective investigation with a history of solid organ transplant and a diagnosis of PTLD ( . In PTLD patients .
In our study, all 19 patients whose EBV viral loads were recorded had elevated levels at the time of presentation.
The type of organ transplant is also a risk factor in development of PTLD. The incidence of PTLD has been reported to vary between 5% and 15% in the cardiac and liver transplants and even higher in intestinal transplants while representing only about 1-3% in the renal transplant recipients 8 . In our study, the higher incidence of PTLD in cardiac transplants may be WHO classifies PTLD into four categories: early lesions, polymorphic PTLD, monomorphic PTLD, and classical Hodgekin's lymphoma-type PTLD 10 . PTLD is hypothesized to progress along a clinic-pathological spectrum based on cytogenetic alterations 10, 16 . In the In our study, only 20% of the patients were diagnosed with early lesions of PTLD while the majority presented with later stages of lymphoma PTLD.
Therefore, most patients required systemic chemotherapy.
One of the limitations of our study is its retrospective nature. Without prospective data collection and categorization, some of the patient charts were incomplete and follow-up was variable. The overall number of included patients was also low due to the low incidence of PTLD. Future prospective, randomized control studies comparing clinical otolaryngological manifestation of PTLD with surveillance imaging studies in pediatric SOT patients will further assist in earlier detection and management of this disease.
Conclusion:
PTLD is a recognized complication of immunosuppression in the post-transplant pediatric population.
Head and neck PTLD with adenotonsillar hypertrophy and cervical lymphadenopathy help early detection of the disease in its early stage, allowing prompt treatment and prevention of further progression.
